innate immunity

AB0258 CLINICAL AND SEROLOGICAL CHARACTERIZATION OF PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES
P. Martinez Calabuig, J. J. Fragío Gil, R. González-Mazarío, S. Moner Marín, L. Salvador Maicas, M. L. Sanmartín Martínez, A. Sierra Rivera, A. Rueda Cid, J. J. Lerma Garrido, C. Molina Almela, C. Campos Fernández

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1370-1371; DOI: 10.1136/annrheumdis-2024-eular.1864
AB0266 TARGETING FIBROSIS TO ADDRESS MYOCARDITIS AS COMPLICATION OF RHEUMATIC DISEASE: PROOF OF CONCEPT IN A LARVAL ZEBRAFISH MODEL
C. Smith, T. Ollewagen

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1375; DOI: 10.1136/annrheumdis-2024-eular.664
AB0268 INCREASED ISG15 EXPRESSION IN PERIPHERAL BLOOD FROM PATIENTS WITH POSITIVE DERMATOMYOSITIS RELATED SPECIFIC AUTOANTIBODIES
C. Mavragani, S. Raftopoulou, N. Michalakeas, M. Gerochristou, N. Marketos, C. Skarlis

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1376-1377; DOI: 10.1136/annrheumdis-2024-eular.1783
AB0280 EXOSOMAL miRNA AS POTENTIAL BIOMARKERS FOR ADULT-ONSET STILL’S DISEASE
M. H. Ahn, J. H. Han, J. Kim, J. W. Kim, J. Y. Jung, C. H. Suh, H. A. Kim

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1383-1384; DOI: 10.1136/annrheumdis-2024-eular.1893
AB0086 COMBINATION THERAPY OF HIGH-DOSE INTRAVENOUS ANAKINRA AND BARICITINIB IN PATIENTS WITH CRITICAL COVID-19: PROMISING RESULTS FROM RETROSPECTIVE OBSERVATIONAL STUDY
M. Bektaş

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1275-1276; DOI: 10.1136/annrheumdis-2024-eular.111
AB0087 INTRAVENOUS HIGH-DOSE ANAKINRA DROPS VENOUS THROMBOSIS AND MYOCARDIAL INFARCTION IN SEVERE AND CRITICAL COVID-19 PATIENTS: A PROPENSITY SCORE MATCHED STUDY
M. Bektaş, M. Ay, M. Uyar, M. İ. Kiliç

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1276; DOI: 10.1136/annrheumdis-2024-eular.112
AB0095 STUDY OF THE ROLE OF THE URATE TRANSPORTER ABCG2 IN THE REGULATION OF THE IMMUNE RESPONSE IN KNOCKOUT MODELS OF HUMAN COLON AND KIDNEY CELLS
A. Lopez Macay, K. Martinez Flores, Y. Zamudio Cuevas, A. Rivera Sanchez, J. Fernandez Torres, M. F. Perez Ruiz, M. Martinez Ramirez, on behalf of liquido sinovial

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1281; DOI: 10.1136/annrheumdis-2024-eular.611
AB0164 NON-TUBERCULOSIS MYCOBACTERIA-INDUCED NETosis AND AUTOANTIBODY DYNAMICS IN NTM INFECTION: A COMPARATIVE STUDY WITH PULMONARY TUBERCULOSIS
Z. Y. Lai, Y. M. Kuo, S. C. Hsieh, C. J. Jung, C. C. Shu

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1316-1317; DOI: 10.1136/annrheumdis-2024-eular.5631
AB0172 SINGLE-CELL PROFILING IDENTIFIES IL1BHI MACROPHAGES ASSOCIATED WITH INFLAMMATION IN PD-1 INHIBITOR-INDUCED INFLAMMATORY ARTHRITIS
H. Yang, Z. Zhou, X. Zhou, X. Jiang, M. Wang, X. Zhang

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1319-1320; DOI: 10.1136/annrheumdis-2024-eular.5602
AB0175 ALTERATIONS IN JAK-STAT SIGNALING PATHWAY ARE FOUND IN PERIPHERAL BLOOD LEUKOCYTES FROM UNTREATED EARLY ARTHRITIS PATIENTS
R. L. Teixeira, A. R. Faísca, C. Tomé, V. C Romão, J. E. Fonseca, I. Alcobia, R. A. Moura

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1321-1322; DOI: 10.1136/annrheumdis-2024-eular.4858

Main menu

innate immunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

innate immunity

Pages